JY
KITE

Jeff Yass’s Kite Pharma, Inc. KITE Stock Holding History

Jeff Yass’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,385,900
Closed -$249M – 10416
2017
Q3 		$249M Buy
1,385,900
+1,041,000
+302% +$145M 0.1% 176
2017
Q2 		$35.8M Buy
344,900
+119,100
+53% +$9.72M 0.02% 778
2017
Q1 		$17.7M Sell
225,800
-107,800
-32% -$6.67M 0.01% 1170
2016
Q4 		$15M Sell
333,600
-335,500
-50% -$16.5M 0.01% 1253
2016
Q3 		$37.4M Buy
669,100
+504,100
+306% +$28.1M 0.02% 663
2016
Q2 		$8.25M Buy
165,000
+18,100
+12% +$889K ﹤0.01% 1620
2016
Q1 		$6.74M Sell
146,900
-10,600
-7% -$513K ﹤0.01% 1937
2015
Q4 		$9.71M Sell
157,500
-21,300
-12% -$1.5M ﹤0.01% 1786
2015
Q3 		$9.96M Sell
178,800
-217,300
-55% -$13.7M ﹤0.01% 1834
2015
Q2 		$24.1M Buy
396,100
+176,100
+80% +$10M 0.01% 1140
2015
Q1 		$12.7M Buy
220,000
+165,100
+301% +$11.1M 0.01% 1634
2014
Q4 		$3.17M Buy
+54,900
New +$2.31M ﹤0.01% 3650

Jeff Yass's KITE Position: Q4 2017 in Review

Jeff Yass sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 158,135 shares — an estimated $28.4M sold.

Jeff Yass first reported a position in KITE in Q4 2014 and held it in 11 quarters. The position peaked at $29.8M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Jeff Yass reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Jeff Yass sold 158,135 Kite Pharma, Inc. shares in Q4 2017, an estimated $28.4M.
  • Jeff Yass first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 11 quarters.
  • Jeff Yass's Kite Pharma, Inc. position peaked at $29.8M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Susquehanna International Group's 13F filing for Q4 2017, filed 14 Feb 2018.